Clinical Research Directory

PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

Sponsor: Usona Institute

Summary

This is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent were enrolled into this study and completed web surveys and telephone interviews conducted by one central site at the following time intervals: months 3 and 6 (± 7 days for each assessment) and months 10 and 12 (± 14 days for each assessment).

Official title: A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control

Key Details

Conditions

Interventions

Locations (1)